Doximity Inc
NYSE:DOCS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
45.93
83.14
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Doximity Inc
Doximity Inc., often regarded as the social network for doctors, has carved a unique niche for itself by seamlessly blending the culture of community with professional networking specifically tailored for the medical field. Founded in 2010 by Jeff Tangney, a co-founder of Epocrates, Doximity leverages technology to connect healthcare professionals nationwide, offering tools for both communication and collaboration. Much like LinkedIn, but with a focus on physicians and clinicians, Doximity provides a platform where medical practitioners can securely connect with colleagues, stay informed about the latest developments in their fields, and peruse professional opportunities. Its services cater not just to social networking, but also to telemedicine, reflecting the modern demands of a rapidly digitizing healthcare landscape.
The company monetizes primarily through three main revenue streams: pharmaceutical marketing, hiring solutions, and telehealth services. Pharmaceutical companies pay Doximity for targeted marketing opportunities, allowing them to reach specific segments of the medical community with precision and impact. Additionally, hospitals and medical groups subscribe to its hiring solutions to recruit top-tier medical talent. In an era where telemedicine has become increasingly vital, Doximity’s telehealth solutions have gained traction, enabling physicians to engage in virtual consultations efficiently. This multi-faceted business model allows Doximity to stay at the forefront of digital healthcare services, driving growth while serving a highly specialized market.
Doximity Inc., often regarded as the social network for doctors, has carved a unique niche for itself by seamlessly blending the culture of community with professional networking specifically tailored for the medical field. Founded in 2010 by Jeff Tangney, a co-founder of Epocrates, Doximity leverages technology to connect healthcare professionals nationwide, offering tools for both communication and collaboration. Much like LinkedIn, but with a focus on physicians and clinicians, Doximity provides a platform where medical practitioners can securely connect with colleagues, stay informed about the latest developments in their fields, and peruse professional opportunities. Its services cater not just to social networking, but also to telemedicine, reflecting the modern demands of a rapidly digitizing healthcare landscape.
The company monetizes primarily through three main revenue streams: pharmaceutical marketing, hiring solutions, and telehealth services. Pharmaceutical companies pay Doximity for targeted marketing opportunities, allowing them to reach specific segments of the medical community with precision and impact. Additionally, hospitals and medical groups subscribe to its hiring solutions to recruit top-tier medical talent. In an era where telemedicine has become increasingly vital, Doximity’s telehealth solutions have gained traction, enabling physicians to engage in virtual consultations efficiently. This multi-faceted business model allows Doximity to stay at the forefront of digital healthcare services, driving growth while serving a highly specialized market.
Revenue Beat: Doximity reported Q2 revenue of $168.5 million, up 23% year-over-year and 7% above the high end of guidance.
Profitability: Adjusted EBITDA margin reached 60% ($100.8 million), up from 56% last year and 15% above guidance.
Guidance Raised: Full-year revenue outlook increased to $640–646 million; adjusted EBITDA guidance raised to $351–357 million.
AI & Integrated Programs: AI tools and integrated programs drove growth, with 40% of Q2 bookings now from integrated offerings (up from 5% last year); AI active users up 50% quarter-over-quarter.
Customer Expansion: 121 customers now spend over $500,000 each (up 16% YoY), with strong growth among SMBs (up 100% YoY in bookings).
Budgeting Uncertainty: Management noted some uncertainty around 2026 client budgets due to policy changes and market conditions, but client engagement remains high.
Health Systems & Recruiting: Enterprise and recruiting businesses showed strong growth, with health systems seen as a long-term growth driver.
Share Repurchases: $21.9 million worth of shares repurchased in Q2; $280 million remains under the current program.